404 related articles for article (PubMed ID: 18342468)
1. Extracellular Gd-CA: differences in prevalence of NSF.
Thomsen HS; Marckmann P
Eur J Radiol; 2008 May; 66(2):180-3. PubMed ID: 18342468
[TBL] [Abstract][Full Text] [Related]
2. MRI contrast media are used to improve visualization of abnormal structures or lesions in various parts of the body. Introduction.
Thomsen HS; Marckmann P
Eur J Radiol; 2008 May; 66(2):153-9. PubMed ID: 18343071
[TBL] [Abstract][Full Text] [Related]
3. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Broome DR
Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic systemic fibrosis: more questions and some answers.
Morcos SK; Thomsen HS
Nephron Clin Pract; 2008; 110(1):c24-31; discussion c32. PubMed ID: 18688172
[TBL] [Abstract][Full Text] [Related]
5. [Nephrogenic systemic fibrosis].
Breitschaft A; Stahlmann R
Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic systemic fibrosis--implications for nephrologists.
Saab G; Abu-Alfa A
Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent.
Rydahl C; Thomsen HS; Marckmann P
Invest Radiol; 2008 Feb; 43(2):141-4. PubMed ID: 18197066
[TBL] [Abstract][Full Text] [Related]
8. An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital.
Marckmann P
Eur J Radiol; 2008 May; 66(2):187-90. PubMed ID: 18328659
[TBL] [Abstract][Full Text] [Related]
9. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
Wiginton CD; Kelly B; Oto A; Jesse M; Aristimuno P; Ernst R; Chaljub G
AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
[TBL] [Abstract][Full Text] [Related]
11. Nephrogenic system fibrosis: a radiologist's practical perspective.
Martin DR
Eur J Radiol; 2008 May; 66(2):220-4. PubMed ID: 18321672
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
[TBL] [Abstract][Full Text] [Related]
13. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P
Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
[TBL] [Abstract][Full Text] [Related]
14. [Nephrogenic systemic fibrosis].
Cavallini L; Abaterusso C; Bedogna V; Pertica N; Loschiavo C; Lupo A
G Ital Nefrol; 2008; 25(1):14-20. PubMed ID: 18264914
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium use in patients with kidney disease: a cause for concern.
Perazella MA; Rodby RA
Semin Dial; 2007; 20(3):179-85. PubMed ID: 17555477
[TBL] [Abstract][Full Text] [Related]
16. [Nephrogenic systemic fibrosis after application of gadolinium-based contrast agents--a status paper].
Heinrich M; Uder M
Rofo; 2007 Jun; 179(6):613-7. PubMed ID: 17497597
[TBL] [Abstract][Full Text] [Related]
17. MRI gadolinium-based contrast agents. Radiologists beware!
Goullé JP; Cattanéo A; Saussereau E; Mahieu L; Guerbet M; Lacroix C
Ann Pharm Fr; 2009 Sep; 67(5):335-9. PubMed ID: 19695369
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).
Khurana A; Runge VM; Narayanan M; Greene JF; Nickel AE
Invest Radiol; 2007 Feb; 42(2):139-45. PubMed ID: 17220732
[TBL] [Abstract][Full Text] [Related]
19. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
Singh M; Davenport A; Clatworthy I; Lewin J; Deroide F; Hubbard V; Rustin MH
Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
[TBL] [Abstract][Full Text] [Related]
20. The impact of NSF on the care of patients with kidney disease.
Abu-Alfa A
J Am Coll Radiol; 2008 Jan; 5(1):45-52. PubMed ID: 18180009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]